Global Human Fibrin Glue Market
Tamaño del mercado en miles de millones de dólares
Tasa de crecimiento anual compuesta (CAGR) :
% 
 Período de pronóstico |
2022 –2029 |
 Tamaño del mercado (año base) |
USD 486.58 Million |
 Tamaño del mercado (año de pronóstico) |
USD 934.68 Million |
 Tasa de crecimiento anual compuesta (CAGR) |
% |
| Jugadoras de los principales mercados |
|
>Mercado mundial de pegamento de fibrina humana, por forma de paquete (líquido, parche, otros), aplicación (cirugía cardíaca, cirugía pulmonar, sangrado por quemaduras, cirugías vasculares, cirugías ortopédicas, laceraciones de hígado y bazo, neurocirugía, cirugía plástica, cirugía general, manejo de heridas, otros), canal de distribución (licitación directa y ventas minoristas), usuario final (hospitales, centros de atención ambulatoria, clínicas especializadas, otros), país (EE. UU., Canadá, México, Alemania, Reino Unido, Francia, Italia, España, Rusia, Países Bajos, Suiza, Turquía, Bélgica, Resto de Europa, China, Japón, India, Corea del Sur, Australia, Singapur, Tailandia, Malasia, Indonesia, Filipinas, Resto de Asia-Pacífico, Sudáfrica, Arabia Saudita, Emiratos Árabes Unidos, Egipto, Israel y resto de Medio Oriente y África, Brasil, Argentina y resto de Sudamérica) Tendencias de la industria y pronóstico hasta 2029.
Análisis y perspectivas del mercado: mercado mundial de pegamento de fibrina humana
Se espera que el mercado mundial de pegamento de fibrina humana alcance los 934,68 millones de dólares en 2029, frente a los 486,58 millones de dólares en 2021, con un crecimiento anual compuesto del 9,2 % en el período previsto de 2021 a 2029. El aumento de los avances tecnológicos y el lanzamiento de nuevos productos han aumentado la demanda de pegamento de fibrina humana a nivel mundial. Sin embargo, el alto coste del diagnóstico está obstaculizando el crecimiento del mercado.
Los pegamentos de fibrina humana intervienen en el proceso de hemostasia y cicatrización de heridas. Un pegamento de fibrina humana (HFG) está hecho de dos componentes contenidos en viales separados: un concentrado liofilizado de proteínas de coagulación, principalmente fibrinógeno, factor XIII y fibronectina (el sellador), y trombina liofilizada (el catalizador), que se aplica a una herida o durante la cirugía para evitar la pérdida de sangre, crear un coágulo para la hemostasia, reducir la estancia hospitalaria y dejar menos cicatrices.
Se prevé que el aumento de las aprobaciones de la FDA y la presencia de importantes actores del mercado aumenten el crecimiento del mercado. Las crecientes inversiones gubernamentales y la concienciación entre la población permiten que el mercado mejore el tratamiento. Sin embargo, se prevé que el creciente retiro de productos suponga un desafío para el mercado.
El informe de mercado de pegamento de fibrina humana proporciona detalles de la participación de mercado, nuevos desarrollos y análisis de la cartera de productos, el impacto de los actores del mercado nacional y localizado, analiza las oportunidades en términos de bolsillos de ingresos emergentes, cambios en las regulaciones del mercado, aprobaciones de productos, decisiones estratégicas, lanzamientos de productos, expansiones geográficas e innovaciones tecnológicas en el mercado. Para comprender el análisis y el escenario del mercado, comuníquese con nosotros para obtener un informe de analista; nuestro equipo lo ayudará a crear una solución de impacto en los ingresos para lograr su objetivo deseado.
Alcance y tamaño del mercado mundial de pegamento de fibrina humana
El mercado del pegamento de fibrina humana se clasifica en cuatro segmentos notables, según la forma del envase, la aplicación, el usuario final y el canal de distribución. El crecimiento entre segmentos le ayuda a analizar nichos de crecimiento y estrategias para abordar el mercado y determinar sus áreas de aplicación principales y la diferencia en sus mercados objetivo.
- On the basis of package form, the human fibrin glue market is segmented into liquid, patch, and others. In 2022, liquid segment is expected to dominate the North America human fibrin glue market, due to increase in blood related complication during surgery, and these human fibrin glues reduce these complication.
- On the basis of application, the human fibrin glue market is segmented into cardiac surgery, pulmonary surgery, burn bleeding, vascular surgeries, orthopedic surgeries, lacerations of liver and spleen, neurosurgery, plastic surgery, general surgery, wound management, and others. In 2022, wound management segment is expected to dominate the North America human fibrin glue market, with the increasing number of product launches.
- On the basis of end user, the human fibrin glue market is segmented into hospitals, ambulatory care centre, speciality clinics, and others. In 2022, hospital segment is expected to dominate the market, due to growing demand of human fibrin glues with in the surgeons.
- On the basis of distribution channel, the human fibrin glue market is segmented into direct tender and retail sales. In 2022, direct tender segment is expected to human fibrin glues market, as the criteria to enter in tender is easy & simpler.
Human Fibrin Glue Market Country Level Analysis
The human fibrin glue market is analysed and market size information is provided on the basis of package form, application, end user and distribution channel.
The countries covered in the global human fibrin glue market report are U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, South Africa, Saudi Arabia, UAE, Egypt, Israel and Rest of the Middle East and Africa, Brazil, Argentina and Rest of South America.
The U.S. is expected to dominate in the North America, due to increase in technological advancement, and chronic diseases. In Asia Pacific, China is projected to dominate the market, due to increase in awareness regarding hemostasis and rise in demand for human fibrin glue. In Europe, Germany is expected to dominate, due to the presence of major market players and increasing minimal invasive surgeries.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
El aumento de los avances y la tecnología para el desarrollo de nuevos productos impulsan el crecimiento del mercado del pegamento de fibrina humana
El mercado de pegamento de fibrina humana también le proporciona un análisis detallado del mercado para cada país, el crecimiento de la industria del pegamento de fibrina humana con las ventas de pegamento de fibrina humana, el impacto del avance en la tecnología del pegamento de fibrina humana y los cambios en los escenarios regulatorios con su apoyo al mercado del pegamento de fibrina humana. Los datos están disponibles para el período histórico de 2010 a 2020.
Análisis del panorama competitivo y de la cuota de mercado del pegamento de fibrina humana
El panorama competitivo del mercado de pegamento de fibrina humana proporciona detalles por competidor. Los detalles incluidos son descripción general de la empresa, estados financieros de la empresa, ingresos generados, potencial de mercado, inversión en investigación y desarrollo, nuevas iniciativas de mercado, sitios e instalaciones de producción, fortalezas y debilidades de la empresa, lanzamiento de productos, líneas de prueba de productos, aprobaciones de productos, patentes, amplitud y amplitud del producto, dominio de la aplicación, curva de vida de la tecnología. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de la empresa relacionado con el mercado de pegamento de fibrina humana.
Algunas de las principales empresas que operan en el mercado mundial de pegamento de fibrina humana (HFG) son Johnson & Johnson Services, Inc., Baxter, CSL Limited, Shanghai RAAS, Corza Health, Marquee Biosurgical y Hualan Biological Engineering, Inc, entre otras. Los analistas de DBMR comprenden las fortalezas competitivas y brindan un análisis competitivo para cada competidor por separado.
Muchos lanzamientos de productos y acuerdos también son iniciados por empresas de todo el mundo que también están acelerando el mercado del pegamento de fibrina humana.
Por ejemplo,
- En diciembre de 2019, Ethicon, parte de la familia de empresas Johnson & Johnson, anunció el lanzamiento del sellador de fibrina VISTASEAL (humano) para ayudar a los cirujanos a controlar el sangrado durante las cirugías, que contiene una combinación de fibrinógeno y trombina, proteínas de coagulación que se encuentran en el plasma humano. Esto ha aumentado la cartera de productos de la empresa.
- En marzo de 2018, Baxter anunció que había completado la adquisición de dos productos hemostáticos y sellantes de Mallinckrodt plc. Esta adquisición ha aumentado su cartera de productos hemostáticos.
La colaboración, el lanzamiento de productos, la expansión comercial, los premios y reconocimientos, las empresas conjuntas y otras estrategias de los actores del mercado están mejorando el mercado de la empresa en el mercado de pegamento de fibrina humana, lo que también proporciona el beneficio para que la organización mejore su oferta de pegamento de fibrina humana.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PACKAGE FORM LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 INDUSTRY INSIGHTS
6 REGULATORY ANALYSIS
6.1.1 REGULATION IN U.S.
6.1.2 REGULATION IN EUROPE
6.1.3 REGULATION IN AUSTRALIA
6.1.4 REGULATION IN CANADA
6.1.5 REGULATION IN CHINA
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASE IN TECHNOLOGICAL ADVANCEMENT
7.1.2 INCREASING SURGICAL PROCEDURES
7.1.3 ADVANTAGES OF HUMAN FIBRIN GLUE
7.1.4 INCREASE IN THE GERIATRIC POPULATION
7.1.5 SUPERIORITY OF FIBRIN SEALANTS, OVER LIMITATIONS OF CONVENTIONAL METHODS
7.2 RESTRAINTS
7.2.1 STRINGENT RULES & REGULATORY
7.2.2 HIGH COST OF PRODUCTS
7.2.3 RISK OF VIRAL INFECTIONS
7.3 OPPORTUNITIES
7.3.1 INCREASE IN PREVALENCE OF CHRONIC DISORDERS
7.3.2 RISE IN MINIMALLY INVASIVE SURGERIES
7.3.3 RISING PLASTIC SURGERIES
7.4 CHALLENGES
7.4.1 COMPLICATION RELATED TO USE OF HUMAN FIBRIN GLUE
7.4.2 LACK OF SKILLED PROFESSIONALS
7.4.3 DECREASED SURGICAL PROCEDURES DUE TO COVID-19
8 IMPACT OF COVID-19 ON GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET
8.1 IMPACT ON PRICE
8.2 IMPACT ON SUPPLY CHAIN
8.3 IMPACT ON DEMAND
8.4 CONCLUSION
9 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM
9.1 OVERVIEW
9.2 LIQUID
9.2.1 1-2 ML
9.2.2 7-10 ML
9.2.3 3-4 ML
9.2.4 5-6 ML
9.3 PATCH
9.4 OTHERS
10 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 SPECIALTY CLINICS
10.4 AMBULATORY CARE CENTER
10.5 OTHERS
11 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
12 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 WOUND MANAGEMENT
12.3 BURN BLEEDING
12.4 PLASTIC SURGERY
12.5 GENERAL SURGERY
12.6 VASCULAR SURGERIES
12.7 LACERATIONS OF LIVER AND SPLEEN
12.8 CARDIAC SURGERY
12.9 PULMONARY SURGERY
12.1 ORTHOPEDIC SURGERIES
12.11 NEUROSURGERY
12.12 OTHERS
13 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION
13.1 OVERVIEW
13.2 NORTH AMERICA
13.2.1 U.S.
13.2.2 CANADA
13.2.3 MEXICO
13.3 EUROPE
13.3.1 GERMANY
13.3.2 U.K.
13.3.3 FRANCE
13.3.4 ITALY
13.3.5 SPAIN
13.3.6 SWITZERLAND
13.3.7 RUSSIA
13.3.8 NETHERLANDS
13.3.9 TURKEY
13.3.10 BELGIUM
13.3.11 REST OF EUROPE
13.4 ASIA-PACIFIC
13.4.1 CHINA
13.4.2 INDIA
13.4.3 JAPAN
13.4.4 SOUTH KOREA
13.4.5 AUSTRALIA
13.4.6 THAILAND
13.4.7 MALAYSIA
13.4.8 SINGAPORE
13.4.9 INDONESIA
13.4.10 REST OF ASIA-PACIFIC
13.5 SOUTH AMERICA
13.5.1 BRAZIL
13.5.2 ARGENTINA
13.5.3 REST OF SOUTH AMERICA
13.6 MIDDLE EAST & AFRICA
13.6.1 SAUDI ARABIA
13.6.2 SOUTH AFRICA
13.6.3 U.A.E
13.6.4 ISRAEL
13.6.5 EGYPT
13.6.6 REST OF MIDDLE EAST AND AFRICA
14 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: GLOBAL
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
14.3 COMPANY SHARE ANALYSIS: EUROPE
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 CSL LIMITED
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 JOHNSON & JOHNSON SERVICES, INC.
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 BAXTER
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 HUALAN BIOLOGICAL ENGINEERING, ING
16.4.1 COMPANY SNAPSHOT
16.4.2 COMPANY SHARE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENT
16.5 SHANGHAI RAAS
16.5.1 COMPANY SNAPSHOT
16.5.2 COMPANY SHARE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENT
16.6 CORZA HEALTH
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 MARQUEE BIOSURGICAL
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
Lista de Tablas
TABLE 1 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 2 GLOBAL LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 GLOBAL LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 4 GLOBAL PATCH IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 GLOBAL OTHERS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 7 GLOBAL HOSPITALS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 8 GLOBAL SPECIALTY CLINICS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 9 GLOBAL AMBULATORY CARE CENTERS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 10 GLOBAL OTHERS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 11 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 12 GLOBAL DIRECT TENDER IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 GLOBAL RETAIL SALES IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 15 GLOBAL WOUND MANAGEMENT IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 GLOBAL BURN BLEEDING IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 GLOBAL PLASTIC SURGERY IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 GLOBAL GENERAL SURGERY IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 GLOBAL VASCULAR SURGERIES IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 GLOBAL LACERATIONS OF LIVER AND SPLEEN IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 GLOBAL CARDIAC SURGERY IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 GLOBAL PULMONARY SURGERY IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 GLOBAL ORTHOPEDIC SURGERIES IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 GLOBAL NEUROSURGERY IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 GLOBAL OTHERS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 26 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 NORTH AMERICA HUMAN FIBRIN GLUE (HFG) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 28 NORTH AMERICA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 29 NORTH AMERICA LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 30 NORTH AMERICA HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 31 NORTH AMERICA HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 32 NORTH AMERICA HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 33 U.S. HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 34 U.S. LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 35 U.S. HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 36 U.S. HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 37 U.S. HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 38 CANADA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 39 CANADA LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 40 CANADA HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 41 CANADA HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 42 CANADA HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 43 MEXICO HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 44 MEXICO LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 45 MEXICO HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 46 MEXICO HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 47 MEXICO HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 48 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 49 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 50 EUROPE LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 51 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 52 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 53 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 54 GERMANY HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 55 GERMANY LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 56 GERMANY HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 57 GERMANY HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 58 GERMANY HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 59 U.K. HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 60 U.K. LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 61 U.K. HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 62 U.K. HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 63 U.K. HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 64 FRANCE HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 65 FRANCE LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 66 FRANCE HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 67 FRANCE HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 68 FRANCE HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 69 ITALY HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 70 ITALY LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 71 ITALY HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 72 ITALY HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 73 ITALY HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 74 SPAIN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 75 SPAIN LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 76 SPAIN HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 77 SPAIN HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 78 SPAIN HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 79 SWITZERLAND HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 80 SWITZERLAND LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 81 SWITZERLAND HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 82 SWITZERLAND HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 83 SWITZERLAND HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 84 RUSSIA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 85 RUSSIA LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 86 RUSSIA HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 87 RUSSIA HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 88 RUSSIA HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 89 NETHERLANDS HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 90 NETHERLANDS LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 91 NETHERLANDS HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 92 NETHERLANDS HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 93 NETHERLANDS HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 94 TURKEY HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 95 TURKEY LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 96 TURKEY HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 97 TURKEY HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 98 TURKEY HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 99 BELGIUM HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 100 BELGIUM LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 101 BELGIUM HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 102 BELGIUM HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 103 BELGIUM HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 104 REST OF EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 105 ASIA-PACIFIC HUMAN FIBRIN GLUE (HFG) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 106 ASIA-PACIFIC HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 107 ASIA-PACIFIC LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 108 ASIA-PACIFIC HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 109 ASIA-PACIFIC HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 110 ASIA-PACIFIC HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 111 CHINA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 112 CHINA LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 113 CHINA HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 114 CHINA HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 115 CHINA HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 116 INDIA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 117 INDIA LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 118 INDIA HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 119 INDIA HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 120 INDIA HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 121 JAPAN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 122 JAPAN LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 123 JAPAN HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 124 JAPAN HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 125 JAPAN HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 126 SOUTH KOREA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 127 SOUTH KOREA LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 128 SOUTH KOREA HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 129 SOUTH KOREA HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 130 SOUTH KOREA HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 131 AUSTRALIA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 132 AUSTRALIA LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 133 AUSTRALIA HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 134 AUSTRALIA HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 135 AUSTRALIA HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 136 THAILAND HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 137 THAILAND LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 138 THAILAND HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 139 THAILAND HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 140 THAILAND HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 141 MALAYSIA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 142 MALAYSIA LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 143 MALAYSIA HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 144 MALAYSIA HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 145 MALAYSIA HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 146 SINGAPORE HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 147 SINGAPORE LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 148 SINGAPORE HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 149 SINGAPORE HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 150 SINGAPORE HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 151 INDONESIA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 152 INDONESIA LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 153 INDONESIA HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 154 INDONESIA HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 155 INDONESIA HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 156 BELGIUM HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 157 SOUTH AMERICA HUMAN FIBRIN GLUE (HFG) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 158 SOUTH AMERICA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 159 SOUTH AMERICA LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 160 SOUTH AMERICA HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 161 SOUTH AMERICA HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 162 SOUTH AMERICA HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 163 BRAZIL HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 164 BRAZIL LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 165 BRAZIL HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 166 BRAZIL HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 167 BRAZIL HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 168 ARGENTINA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 169 ARGENTINA LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 170 ARGENTINA HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 171 SOUTH AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 172 SOUTH AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 173 REST OF SOUTH AMERICA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 174 MIDDLE EAST & AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 175 MIDDLE EAST & AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 176 MIDDLE EAST & AFRICA LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 177 MIDDLE EAST & AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 178 MIDDLE EAST & AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 179 MIDDLE EAST & AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 180 SAUDI ARABIA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 181 SAUDI ARABIA LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 182 SAUDI ARABIA HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 183 SAUDI ARABIA HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 184 SAUDI ARABIA HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 185 SOUTH AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 186 SOUTH AFRICA LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 187 SOUTH AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 188 SOUTH AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 189 SOUTH AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 190 U.A.E HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 191 U.A.E LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 192 U.A.E HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 193 U.A.E HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 194 U.A.E HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 195 ISRAEL HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 196 ISRAEL LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 197 ISRAEL HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 198 ISRAEL HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 199 ISRAEL HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 200 EGYPT HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 201 EGYPT LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 202 EGYPT HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 203 EGYPT HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 204 EGYPT HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 205 REST OF MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
Lista de figuras
FIGURE 1 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: SEGMENTATION
FIGURE 2 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: DBMR MARKET POSITION GRID
FIGURE 8 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: SEGMENTATION
FIGURE 11 THE INCREASE IN DEMAND FOR HUMAN FIBRIN GLUES ARE EXPECTED TO DRIVE THE GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 LIQUID IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET IN 2022 AND 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET
FIGURE 14 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: BY PACKAGE FORM, 2021
FIGURE 15 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: BY PACKAGE FORM, 2022-2029 (USD MILLION)
FIGURE 16 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: BY PACKAGE FORM, CAGR (2022-2029)
FIGURE 17 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: BY PACKAGE FORM, LIFELINE CURVE
FIGURE 18 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: BY END USER, 2021
FIGURE 19 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 20 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: BY END USER, CAGR (2022-2029)
FIGURE 21 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: BY END USER, LIFELINE CURVE
FIGURE 22 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 23 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 24 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 25 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 26 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: BY APPLICATION, 2021
FIGURE 27 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 28 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 29 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 30 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: SNAPSHOT (2021)
FIGURE 31 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: BY REGION (2021)
FIGURE 32 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: BY REGION (2022 & 2029)
FIGURE 33 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: BY REGION (2022 & 2029)
FIGURE 34 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: BY PACKAGE FORM (2022-2029)
FIGURE 35 NORTH AMERICA HUMAN FIRBIN GLUE (HFG) MARKET: SNAPSHOT (2021)
FIGURE 36 NORTH AMERICA HUMAN FIRBIN GLUE (HFG) MARKET: BY COUNTRY (2021)
FIGURE 37 NORTH AMERICA HUMAN FIRBIN GLUE (HFG) MARKET: BY COUNTRY (2022 & 2029)
FIGURE 38 NORTH AMERICA HUMAN FIRBIN GLUE (HFG) MARKET: BY COUNTRY (2021 & 2029)
FIGURE 39 NORTH AMERICA HUMAN FIRBIN GLUE (HFG) MARKET: BY PACKAGE FORM (2022-2029)
FIGURE 40 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET : SNAPSHOT (2021)
FIGURE 41 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET : BY COUNTRY (2021)
FIGURE 42 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET : BY COUNTRY (2022 & 2029)
FIGURE 43 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET : BY COUNTRY (2021 & 2029)
FIGURE 44 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET : BY PACKAGE FORM (2022-2029)
FIGURE 45 ASIA-PACIFIC HUMAN FIBRIN GLUE (HFG) MARKET : SNAPSHOT (2021)
FIGURE 46 ASIA-PACIFIC HUMAN FIBRIN GLUE (HFG) MARKET : BY COUNTRY (2021)
FIGURE 47 ASIA-PACIFIC HUMAN FIBRIN GLUE (HFG) MARKET : BY COUNTRY (2022 & 2029)
FIGURE 48 ASIA-PACIFIC HUMAN FIBRIN GLUE (HFG) MARKET : BY COUNTRY (2021 & 2029)
FIGURE 49 ASIA-PACIFIC HUMAN FIBRIN GLUE (HFG) MARKET : BY PACKAGE FORM (2022-2029)
FIGURE 50 SOUTH AMERICA HUMAN FIBRIN GLUE (HFG) MARKET: SNAPSHOT (2021)
FIGURE 51 SOUTH AMERICA HUMAN FIBRIN GLUE (HFG) MARKET: BY COUNTRY (2021)
FIGURE 52 SOUTH AMERICA HUMAN FIBRIN GLUE (HFG) MARKET: BY COUNTRY (2022 TO 2029)
FIGURE 53 SOUTH AMERICA HUMAN FIBRIN GLUE (HFG) MARKET: BY COUNTRY (2021 TO 2029)
FIGURE 54 SOUTH AMERICA HUMAN FIBRIN GLUE (HFG) MARKET: BY PACKAGE FORM (2022-2029)
FIGURE 55 MIDDLE EAST & AFRICA HUMAN FIBRIN GLUE (HFG) MARKET : SNAPSHOT (2021)
FIGURE 56 MIDDLE EAST & AFRICA HUMAN FIBRIN GLUE (HFG) MARKET : BY COUNTRY (2021)
FIGURE 57 MIDDLE EAST & AFRICA HUMAN FIBRIN GLUE (HFG) MARKET : BY COUNTRY (2022 TO 2029)
FIGURE 58 MIDDLE EAST & AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: BY COUNTRY (2021 TO 2029)
FIGURE 59 MIDDLE EAST & AFRICA HUMAN FIBRIN GLUE (HFG) MARKET : BY PACKAGE FORM (2022-2029)
FIGURE 60 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: COMPANY SHARE 2021 (%)
FIGURE 61 NORTH AMERICA HUMAN FIBRIN GLUE (HFG) MARKET: COMPANY SHARE 2021 (%)
FIGURE 62 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: COMPANY SHARE 2021 (%)
FIGURE 63 ASIA-PACIFIC HUMAN FIBRIN GLUE (HFG) MARKET: COMPANY SHARE 2021 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
